US Broker Ratings

Waters Corporation (WAT) Stock Analysis: Revenue Growth Soars Over 113% Amid Strategic Expansion

Waters Corporation (NYSE: WAT), a prominent player in the Healthcare sector, specifically within the Diagnostics & Research industry, presents an intriguing opportunity for investors seeking exposure to the burgeoning analytical..

Johnson & Johnson (JNJ)

⚠️ No article content returned.

..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 17% Upside Potential in the Healthcare Sector

Investors looking for opportunities in the healthcare sector would do well to consider Koninklijke Philips N.V. (NYSE: PHG), a prominent player in the medical devices industry. With a market capitalization..

Mettler-Toledo International, Inc. (MTD): Stock Analysis Reveals 5.28% Potential Upside in Diagnostics & Research Sector

For investors looking to delve into the healthcare sector, Mettler-Toledo International, Inc. (NYSE: MTD) represents a compelling opportunity within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, this company,..

UnitedHealth Group (UNH) Stock Analysis: Exploring a 21.82% Upside with Strong Buy Ratings

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, continues to capture investor attention with its robust market position and promising growth prospects. With a market capitalization of..

Cencora, Inc. (COR) Stock Analysis: A Healthcare Giant with a 16% Upside Potential

Cencora, Inc. (NYSE: COR), a major player in the healthcare sector, has captured the attention of investors with its strategic positioning in the medical distribution industry. With a market cap..

Bristol-Myers Squibb (BMY) Investor Outlook: Navigating Healthcare Growth Amidst Mixed Ratings

Bristol-Myers Squibb Company (NYSE: BMY) stands as a significant player in the healthcare sector, specifically within the general drug manufacturing industry. With a robust market capitalization of $136.88 billion, this..

Eli Lilly (LLY) Investor Outlook: Navigating Growth and Strong Analyst Ratings in the Healthcare Sector

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its robust growth trajectory and favorable analyst ratings. With a staggering market..

Vertex Pharmaceuticals (VRTX) Stock Analysis: Strong Revenue Growth and Promising Drug Pipeline Propel Investor Interest

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX), a leading biotechnology company based in Boston, continues to capture investor attention with its robust market position and innovative pharmaceutical developments. With a current market..

Elevance Health, Inc. (ELV) Stock Analysis: Riding a 12.12% Potential Upside with Strong Analyst Support

Elevance Health, Inc. (NYSE: ELV) stands as a formidable entity in the healthcare plans sector, boasting a substantial market capitalization of $86.86 billion. This Indianapolis-based company, formerly known as Anthem,..

The Cigna Group (CI) Stock Analysis: Unveiling a 23.03% Upside Potential

For investors keen on the healthcare sector, The Cigna Group (NYSE: CI) presents an intriguing opportunity with a potential upside of 23.03% based on the average target price of $341.42...

AbbVie Inc. (ABBV) Stock Analysis: A Healthcare Giant with a 4.39% Upside Potential

AbbVie Inc. (ABBV), a powerhouse in the healthcare sector, continues to capture investor attention with its robust market presence and promising future prospects. With a market capitalization of $468.22 billion,..

AstraZeneca PLC (AZN) Stock Analysis: Exploring a 28.93% Upside Potential

AstraZeneca PLC (AZN), a leader in the healthcare sector, stands out in the general drug manufacturing industry with its impressive $257.42 billion market cap. As investors assess the company’s performance..

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 79% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the healthcare sector, specifically within the biotechnology industry, is making noticeable strides with its innovative suite of plasma-derived biologics. The company,..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating the Healthcare Device Sector with a Market Cap of $4.26 Billion

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, operates within the specialized niche of medical devices. With a robust market capitalization of $4.26 billion, Integer Holdings..

iRhythm Holdings (IRTC) Stock Analysis: A 39.87% Upside Opportunity in the Medical Device Sector

iRhythm Holdings, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector, thanks to its innovative approach to cardiac monitoring technology. With a market capitalization of $4.17 billion, this San..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: 94.70% Potential Upside Catches Investor Attention

Atrium Therapeutics, Inc. (NASDAQ: RNA) is generating buzz in the biotechnology sector, not only for its innovative approach to RNA-based therapies but also for its significant potential upside that has..

Oscar Health, Inc. (OSCR) Investor Outlook: Evaluating Strong Revenue Growth Amid High RSI Levels

As Oscar Health, Inc. (OSCR) navigates the competitive landscape of the healthcare plans industry, investors are taking note of its impressive market cap of $10.11 billion and a current stock..

BrightSpring Health Services (BTSG) Investor Outlook: Strong Buy Ratings Highlight a Potential 27.92% Upside

BrightSpring Health Services, Inc. (NASDAQ: BTSG) has emerged as a compelling proposition for investors, particularly within the healthcare sector’s innovative health information services industry. With a robust market capitalization of..

Search

Funds

US Broker Ratings

PPHE Hotel Group completes $33.5m sale of Manhattan development site

PPHE Hotel Group has completed the sale of its Manhattan development site for $33.5m, with proceeds to be allocated under its capital strategy...
Search

Funds

US Broker Ratings

FTSE 100

Funds